Roivant - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeRoivant
Roivant logo

Roivant

0 followers

ROIV

Performance

About Roivant

Roivant is a biotech and healthcare technology company that builds nimble, entrepreneurial companies called Vants to accelerate discovery, development, and commercialization of medicines. The group emphasizes sourcing talent, aligning incentives, and deploying technology across its portfolio to move medicines faster to patients. With a global footprint including offices in New York and Basel, Roivant operates through diverse companies focused on transformative therapies and related technologies.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Matt Gline

Chief Executive Officer

Eric Venker

President, Roivant Sciences and CEO, Immunovant

Alex Gasner

Executive Vice President, Roivant Health

Eric Valeur

Vice President, Head of Drug Discovery

Key Facts

HQ Location

United States

Founded

2014

Employees

201 - 500

Status

Public

Website

https://roivant.com